Home   >   Publications   >   Posters & Abstracts

Posters

2017

2017
Pearson, H.
4th Canadian Cancer Research Conference
Genomic biomarkers of response to checkpoint inhibitor immunotherapy in the Personalized OncoGenomics cohort.
2017
Pleasance, E.
CCRC
Personalized Oncogenomics: Whole Genome and Transcriptome Sequencing Informs Treatment Decisions in the Cancer Clinic.
2017
Pearson, H.
CCRC
Genomic biomarkers of response to checkpoint inhibitor immunotherapy in the Personalized OncoGenomics cohort.
2017
Williamson, L.
CCRC
Genomic Profiling of Pancreatic Ductal Adenocarcinoma Identifies DNA Repair Deficient Subtype.
2017
Bonakdar, M.
CCRC
Comprehensive Bioinformatics Analysis of Whole Genome and Transcriptome Sequence Data from Individual Patient Tumours.
2017
Thibodeau, M.
CCRC
Whole-Genome and Whole-Transcriptome Profiling of a Metastatic Eccrine Porocarcinoma.
2017
Karasinska, J.
Keystone Tumor Metabolism meeting
Prognostic metabolic signature associated with mutant KRAS copy gain in pancreatic ductal adenocarcinoma.
2017
Roscoe, R.
Society of Research Administrators International (SRAi)
Personalized OncoGenomics Project (POG) - Program Management and Process Development.
2017
Lim, H.
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology.
2017
Shen, Y.
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Clinical application of whole genome and transcriptome sequencing in cancer care.
2017
Shen, Y.
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics
Clinical application of whole genome and transcriptome sequencing in cancer care.
2017
Zhao, E.
AACR
Breast Cancer Whole Genomes Link Homologous Recombination Deficiency (HRD) with Therapeutic Outcomes.
2017
Bonakdar, M.
AGBT
Bioinformatics for Personalized Oncogenomics: Analysis of whole genome and transcriptome data from individual patient tumours.
2017
Ma, Y.
AGBT
Bioinformatics for Personalized Oncogenomics: Lessons learned from analyzing whole genomes and transcriptomes from 500 patients.
2017
Jones, M.
AGBT Precision Health
Taking whole genomes to the cancer clinic: Integrative analysis for interpretation and communication of whole genome and transcriptome analysis at a tumour board.
2017
Lim, H.
ASCO
Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology.
2017
Tsang, E.
ASCO
Clinical Outcomes after Whole Genome Sequencing in Patients with Metastatic Non Small Cell Lung Cancer.
2017
Chooback, N.
CAMO
Whole genome sequencing (WGS) analysis of lung adenocarcinoma: elucidating the molecular signature.
2017
Pleasance, E.
Personalized Medicine Summit
Personalized Oncogenomics: Whole Genome and Transcriptome Sequencing Informs Treatment Decisions in the Cancer Clinic.
2017
Bonakdar, M.
Personalized Medicine Summit
Comprehensive Bioinformatics Analysis of Whole Genome and Transcriptome Sequence Data from Individual Patient Tumours.

2016

2016
Schrader, I.
AACR
Genomic analysis of pancreatic ductal adenocarcinoma in a patient with MUTYH-associated polyposis.
2016
Laskin, J.
AACR
Restrictions on access to systemic therapy limit the application of whole genome sequencing in clinical care.
2016
Jones, M.
AGBT
Utilization of Whole Genome Analysis Approaches for Personalized Therapy Decision Making in Patients with Advanced Malignancies.
2016
Moore, R.
AGBT
Whole Genome and Transcriptome sequencing for Personalized Cancer Therapy: Lessons learned from first 300 cases.
2016
Zhao, E.
CITAC
Guiding Platinum-based Chemotherapy in Breast Cancer with a Somatic Mutation Signature of Homologous Recombination Deficiency.
2016
Grewal, J.
TFRI- Node
“Using machine learning to identify site of origin of metastatic tumours”.

2015

2015
Sun, S.
AACR
Personalized OncoGenomic in advanced stage breast cancer.
2015
Bose, P.
AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy
Integrated genomic analysis of a recurrent ghost cell odontogenic carcinoma.
2015
Moore, R.
AGBT
Utilization of Whole Genome Analysis Approaches for Personalized Therapy Decision Making in Patients with Advanced Malignancies.
2015
Ma, Y.
AGBT
A bioinformatics pipeline for analyzing whole genome and transcriptome sequence data from individual patient tumours .
2015
Koyama, T.
American Society of Human Genetics
Case Analysis of Advanced Cancers with Watson Genomic Analytics.
2015
Rassekh, R.
ASPHO
Pediatric Personalized Oncogenomics (PedsPOG) – Initial outcomes.
2015
Fok, A.
Canadian GE3LS and Health Services & Policy Research Conference
Management of Germline Findings Revealed Throughout the Course of Tumor-Normal Whole Genome Sequencing in Oncology.
2015
Zhao, E.
Clinician Investigator Program Research Fellow Day
Searching for Targetable Mutation Signatures in a Mixed Cancer Cohort.
2015
Lim, H.
ESMO
Management of Germline Findings Revealed Throughout the Course of Tumor-Normal Whole Genome Sequencing in Oncology.
2015
Zhao, E.
Personalized Medicine Summit
Searching for Targetable Mutation Signatures in a Mixed Cancer Cohort.
2015
Jones, M.
Personalized Medicine Summit
Utilization of Whole Genome Analysis Approaches for Personalized Therapy Decision Making in Patients with Advanced Malignancies.
2015
Roscoe, R.
Personalized Medicine Summit
Management of a large -scale personalized medicine project .
2015
Sheffield, B.
USCAP
Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma using Whole Genome Sequencing.
2015
Yip , S.
USCAP
Next Generation Pathology: The Integration of Next Generation Sequencing With Glass-Based Histomorphology and Immunohistochemistry.

2014

2014
Mungall, A.
3rd TCGA Symposium
“Using TCGA data to inform on precision medicine in late-stage cancer settings”.
2014
Jones, M.
7th Annual RECOMB/ISCB Conference on Regulatory & Systems Genomics with DREAM Challenges
Utilization of Whole Genome Analysis Approaches for Personalized Therapy Decision Making in Patients with Advanced Malignancies.
2014
Laskin, J.
AACR
Whole genome sequencing is superior to cancer panels to aid in decision-making in patients with advanced malignancies.
2014
Kasaian, K.
AACR
Bioinformatic Analyses Approaches for Personalized Oncogenomics.
2014
Zhao, E.
Clinician Investigator Trainee Association of Canada Annual General Meeting
Networks, signatures, and personalized medicine: a whole genome approach to cancer therapy.
2014
Lim, H.
ESMO
Practical guidance for ethical and policy issues that arise from the clinical application of whole genome sequencing in cancer patients.
2014
Kasaian, K.
Genome BC SBN
Bioinformatic Analyses Approaches for Personalized Oncogenomics.
2014
Jones, M.
TFRI- Node
Utilization of Whole Genome Analysis Approaches for Personalized Therapy Decision Making in Patients with Advanced Malignancies.
2014
Rassekh, R.
TFRI- Node
Pediatric Personalized Oncogenomics(PEDSPOG) – Initial outcome.

2012

2012
Li et al.
TFRI- Node
Utilization of genomic information to help guide personalized therapy decision making in patients with incurable malignancies.

Abstracts

2018

2018
Murchison, S.
CARO
Establishing a role for tumor genomics in radiation medicine: an analysis of head and neck cancer patients enrolled in the Personalized Onco-Genomics (POG) initiative.
2018
Moore, R.
AGBT
Utilization of Whole Genome Analysis Approaches for Personalized Therapy Decision Making in Patients with Advanced Malignancies.
2018
Liu, L.
ASCO
Clinical Utility of Whole Genome Sequencing (WGS) in Metastatic Colorectal Cancer (MCRC): Results from the Personalized Oncogenomics Program (POG).

2017

2017
Yang et al.
G Research Day at UBC
Molecular characterization of pancreatic neuroendocrine tumours using whole genome and transcriptome sequencing. B.I.

2016

2016
Laskin, J.
ESMO
Clinicians identify high need to increase their genomic literacy to applied cancer genomics. .
2016
Koyama, T.
ASCO
Watson Genomic Analytics efficiently interprets whole genome sequencing data from cancer patients with advanced disease at high throughput.
2016
Lever, J.
Biocreative conference
CancerMine: A knowledgebase of cancer drivers for personalised cancer treatment.
2016
Ho, C.
ESMO
The incorporation of tumor whole genome sequencing in practice: The impact on clinical decision-making and therapeutic choices).
2016
Laskin, J.
ESMO
Availability of tumour gene expression data facilitates clinical decision-making for patients with advanced cancers.